InvestSMART

Lumos Diagnostics Holdings Limited (ASX:LDX)

ALERT: Price-sensitive ASX Announcement for LDX
Current share price for LDX : $0.110 -0.155 (-58.49%)+
Announcement
Release
25 Mar 2026 9:21AM
Price at Release
$0.265
Full Release
download
Summary
Lumos Diagnostics Holdings Limited requested a trading halt for its securities on the Australian Securities Exchange as of 25 March 2026, pending a forthcoming announcement. This halt is in accordance with ASX Listing Rule 17.1 and is intended to manage continuous disclosure obligations while awaiting an update related to the FDA response to the FebriDx CLIA waiver application. The halt will last until the earlier of the announcement being made or the commencement of normal trading on 27 March 2026.
Key Points
  • Trading in the securities of Lumos Diagnostics Holdings Limited is halted.
  • The halt is pending a market announcement related to an update on the FDA response to the FebriDx CLIA waiver application.
  • The trading halt is requested under ASX Listing Rule 17.1.
  • The halt will last until the earlier of a market announcement or normal trading on 27 March 2026.
  • The company aims to manage its continuous disclosure obligations with this trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.